Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Status:
Not yet recruiting
Trial end date:
2032-12-01
Target enrollment:
Participant gender:
Summary
In patients with multiple myeloma-related acute kidney injury, compare the renal outcome of
chemotherapy combined with HFR-SUPRA to chemotherapy combined with hemodialysis.